Abstract
References
1.
Feibel J.H.
,
Schiffer R.B.
Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report . Am J Psychiatry 1981 ; 138 : 1115 –16
2.
Castillo E.
,
Rubin R.T.
,
Holsboer-Trachsler E.
Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome . Am J Psychiatry 1989 ; 146 : 324 –8
3.
Granato J.E.
,
Stern B.J.
,
Ringel A.
Neuroleptic malignant syndrome: successful treatment with dantrolene and bromocriptine . Ann Neurol 1983 ; 14 : 89 –90
4.
Rosebush P.
,
Stewart T.
A prospective analysis of 24 episodes of neuroleptic malignant syndrome . Am J Psychiatry 1989 ; 146 : 717 –25
5.
Bernstein J.G.
Psychotropic drug prescribing . In:
Hackett T.P.
,
Cassem N.H.
, eds. Massachusetts General Hospital handbook of general hospital psychiatry , 2nd edn. Littleton, MA : PSG Publishing Co , 1987 : 542 –8
6.
Rosebush P.I.
,
Stewart T.D.
,
Gelenberg A.J.
Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients . J Clin Psychiatry 1989 ; 50 : 295 –8
7.
Potkin G.
,
Yucun S.
,
Dongfeng Z.
Does a therapeutic window for plasma Haloperidol exist? Preliminary Chinese data . Psychopharmacol Bull 1985 ; 21 : 59 –62
8.
Van Putten T.
,
Marde S.R.
,
Mintz J.
Plasma Haloperidol level, clinical response and fancy mathematics . Arch Gen Psychiatry 1985 ; 42 : 835
9.
Van Putten T.
,
Marder S.R.
,
May P.R.A.
Is a plasma level of Haloperidol clinically useful? Psychopharmacol Bull 1985 ; 21 : 69 –72
10.
Levenson J.L.
Neuroleptic malignant syndrome . Am J Psychiatry 1985 ; 142 : 1137 –45
11.
Susman V.L.
,
Addonizio G.
Reinduction of neuroleptic malignant syndrome by lithium . J Clin Psychopharmacol 1987 ; 7 : 334 –41
12.
Levinson D.F.
,
Simpson G.H.
Neuroleptic induced extrapyramidal symptoms with fever . Arch Gen Psychiatry 1986 ; 43 : 839 –48
13.
Shalev A.
,
Munitz H.
The neuroleptic malignant syndrome: agent and host interaction . Acta Psychiatr Scand 1986 ; 73 : 337 –47